Marie Boltz

Dr. Marie Boltz

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 September 2018 in Trials
Verified
Journal Article
Open access
PDF file
MBMarie Boltz
Marie Boltz
AKAshley Kuzmik
Ashley Kuzmik
BRBarbara Resnick
Barbara Resnick
RTRebecca Trotta
Rebecca Trotta
JMJacqueline Mogle
Jacqueline Mogle
JGJames E. Galvin
James E. Galvin
Hospitalized older persons with Alzheimer’s disease and related dementias are at greater risk for functional decline and increased care dependency after discharge due to a combination of intrinsic factors, environmental, policy, and care practices that restrict physical and cognitive activity, lack of family involvement and limited staff knowledge of dementia care. We have developed a theory-based intervention, Family centered Function-focused Care, that incorporates an educational empowerment model for family caregivers (FCGs) provided within a social-ecological framework to promote specialized care to patients with dementia during hospitalization and the 60-day post-acute period. Primary aims are to test the efficacy of the intervention in improving physical and cognitive recovery in hospitalized persons living with Alzheimer’s disease and related dementias (ADRD) and improving FCG preparedness and experiences. We will implement Family centered Function-focused Care in a cluster-randomized trial of 438 patient/FCG dyads in six hospital units randomized within three hospitals. We hypothesize that patients who receive the intervention will demonstrate better physical function, less delirium occurrence and severity, neuropsychiatric symptoms, and depression compared to those in the control condition (Education-only). We also hypothesize that FCGs enrolled in Family centered Function-focused Care will experience increased preparedness for caregiving, and less strain, burden, and desire to institutionalize, as compared to FCGs the control group. We will also examine the costs and relative cost savings associated with the intervention and will evaluate the cultural appropriateness of Family centered Function-focused Care for families from diverse backgrounds. Our theory-based intervention makes use of real-world applicable approaches in a novel and innovative way to change the paradigm of how we currently look at acute care and post-acute transitions in persons with ADRD. ClinicalTrials.gov, ID: NCT03046121 . Registered on 8 February 2017.

26 May 2023 in IEEE Transactions on Robotics
Verified
Journal Article
Closed access
FYFengpei Yuan
Fengpei Yuan
MBMarie Boltz
Marie Boltz
DBDania Bilal
Dania Bilal
YJYing-Ling Jao
Ying-Ling Jao
MCMonica Crane
Monica Crane
XZXiaopeng Zhao
Xiaopeng Zhao
Reminiscence therapy (RT) can improve the mood and communication of persons living with Alzheimer's disease and Alzheimer's-disease-related dementias (PLWD). Traditional RT requires professionals' facilitation, limiting its accessibility to PLWD. Social robotics has the potential to facilitate RT, enabling accessible home-based RT. However, studies are needed to investigate how PLWD would perceive a robot-mediated reminiscence therapy (RMRT) and how to develop RMRT for positive user experience and successful adoption. In this article, we develop a prototype of RMRT using a humanoid social robot and test it with 12 participants (seven PLWD, two with mild cognitive impairment, and three informal caregivers). The robot automatically displays a memory trigger on its tablet and engages participants in a relatable conversation during RMRT. A mixed-method approach is employed to assess its acceptability and usability. Our results show that PLWD have an overall positive user experience with the RMRT. Participants laugh and sing along with the robot during RMRT and demonstrate intention to use it. In addition, we discuss a robot control method and several critical problems for RMRT. The RMRT can facilitate both verbal and nonverbal social interaction for PLWD and holds promise for engaging, personalized, and efficient home-based cognitive exercises for PLWD.

10 September 2020 in Pain Management Nursing
Verified
Journal Article
Closed access
MBMarie Boltz
Marie Boltz
BRBarbara Resnick
Barbara Resnick
AKAshley Kuzmik
Ashley Kuzmik
JMJacqueline Mogle
Jacqueline Mogle
JJJoanne Roman Jones
Joanne Roman Jones
JGJames E. Galvin
James E. Galvin

3 April 2019 in Clinical Nursing Research
Verified
Journal Article
Open access
PDF file
BRBarbara Resnick
Barbara Resnick
AKAnn Kolanowski
Ann Kolanowski
KHKimberly Van Haitsma
Kimberly Van Haitsma
EGElizabeth Galik
Elizabeth Galik
MBMarie Boltz
Marie Boltz
SZShijun Zhu
Shijun Zhu
This study described current use and predictors of psychotropics among residents with moderate to severe cognitive impairment. This was a secondary data analysis using baseline data from the first 341 residents in an ongoing trial. Predictive measures included age, gender, race, depressive symptoms, agitation, resistiveness to care, depression, cognition, pain, comorbidities, facility factors, and state. Overall 63% (n = 211) received at least one psychotropic medication, 16% (n = 52) an anti-seizure medication, 23% (n = 77) an anxiolytic, 30% (n = 99) an antidepressant, 2% (n = 8) a sedative hypnotic, 28% (n = 93) an antipsychotic medication, and 9% (n = 29) an opioid. Testing of models explained 9% to 15% of psychotropic medication use. There were high rates of psychotropic medication use and a limited association between demographic factors, behavioral symptoms, and psychotropic medication use. Continued research is needed to explore the impact of deprescribing, person-centered behavioral interventions, and beliefs of providers on psychotropic medication use.

24 March 2022 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
YJYing-Ling Jao
Ying-Ling Jao
JWJulian Wang
Julian Wang
YLYo-Jen Liao
Yo-Jen Liao
JPJyotsana Parajuli
Jyotsana Parajuli
DBDiane Berish
Diane Berish
MCMargaret Calkins
Margaret Calkins
Background and Objectives: Behavioral and psychological symptoms of dementia (BPSD) commonly occur in persons living with dementia. Bright light (BL) interventions have shown some positive impact on BPSD. Ambient lighting is a more efficient approach to delivering BL with better compliance and less staff workload than individual-based lighting interventions. Yet, its effect has not been systematically reviewed. This review synthesized research evidence on the effect of ambient BL on BPSD. Research Design and Methods: This review searched literature from PubMed (Medline), CINAHL, Scopus, Web of Science, and Cochrane in February 2021. Original research testing the effect of ambient BL on BPSD in persons with dementia was included. Two reviewers independently screened, extracted data, and assessed the quality of each article. Results: Nine studies were reviewed with 1 randomized controlled trial and 8 quasi-experimental studies. The sample size ranged from 14 to 89 participants across care settings. While not all studies showed positive results, evidence from multiple studies revealed the positive effect of ambient BL on depressive symptoms and agitation in persons with dementia. The ambient BL that showed a positive effect targeted at approximately 350–750 lux, 4,500–9,325 K, and/or circadian stimulus = 0.375–0.4 for 10–12 hr a day for 4 weeks or longer. Evidence on other BPSD was mixed or too limited to draw conclusions. Discussion and Implications: A preponderance of evidence suggests that, when properly designed and implemented, ambient BL shows promise in reducing depressive symptoms and agitation. Future research, using more rigorous designs, is needed to further test the effect of ambient BL on BPSD with attention to lighting parameters, measurement approaches, and intervention fidelity.

5 February 2022 in Innovation in Aging
Verified
Journal Article
Open access
PDF file
JSJustine Sefcik
Justine Sefcik
MBMarie Boltz
Marie Boltz
MDMaria Dellapina
Maria Dellapina
LGLaura N Gitlin
Laura N Gitlin
Background and Objectives: Several systematic reviews exist that examine the efficacy of educational interventions in randomized controlled trials (RCTs) designed to improve formal caregivers’ knowledge and skills and/or the outcomes of persons living with dementia. The aim of this article is to summarize existing systematic reviews to assess the effectiveness of educational interventions tested in RCTs and directed at formal caregivers. Research Design and Methods: Smith et al.’s methodology guided this systematic review of systematic reviews. We used the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and the A MeaSurement Tool to Assess systematic Reviews 2 (AMSTAR 2) for quality appraisals. Reviews were included if they contained interventions with an RCT design that focused on changing staff behavior and/or practice toward persons living with dementia, in any setting and for any health care discipline. Results: We identified six systematic reviews, one rated as high-quality on the AMSTAR 2. Most interventions were directed at nursing staff, in long-term care facilities, focused on agitation, and were atheoretical. There is insufficient evidence to guide implementation of currently tested interventions; however, training in communication skills, person-centered care, and dementia-care mapping with supervision show promise for improving agitation. Discussion and Implications: There’s a critical need for additional research with well-designed RCTs, and clear reporting of protocols and findings to inform the field on how best to train and support the workforce. Although there is no conclusive evidence on what interventions are most effective, it could be argued that providing training using interventions with modest evidence of impact is better than no training at all until the evidence base is strengthened.